Back to search

Article

Multicenter, Real-World Observational Study of AVA Therapy Following ELT/HET Switching in Chinese Children with Persistent/Chronic Primary ITP

2025-03-27

Abstract excerpt

<title>Abstract</title> <p>Avatrombopag (AVA), a second-generation thrombopoietin receptor agonist (TPO-RA), has demonstrated efficacy in pediatric persistent/chronic immune thrombocytopenia (ITP). However, critical evidence gaps persist regarding treatment-switching strategies between TPO-RAs, particularly when transitioning from eltrombopag (ELT) or hetrombopag (HET) to AVA. This multicenter cohort study evalua...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ffc0be1-7704-5203-9127-f19acde1d587
DOI
10.21203/rs.3.rs-6187960/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Multicenter, Real-World Observational Study of AVA Therapy Following ELT/HET Switching in Chinese Children with Persistent/Chronic Primary ITPDOI 10.21203/rs.3.rs-6187960/v1
Select a neighboring publication to make it the new centre.